A Multicenter, open-label phase 1/2 study of TYRA 300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 gene alterations (SURF301) Meeting Abstract
| Authors: | Zhang, A.; Boni, V.; Hanson, A.; Mantia, C.; Weickhardt, A.; Yu, E.; Gupta, S.; Robert, M.; Iyer, G.; Millward, M.; Morales-Barrera, R.; Hoimes, C.; Berlin, J.; Mittal, K.; Hill, A.; Racca, F.; Pouessel, D.; Lihou, C.; Tran, B.; Loriot, Y. |
| Abstract Title: | A Multicenter, open-label phase 1/2 study of TYRA 300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 gene alterations (SURF301) |
| Meeting Title: | 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 211 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 23-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S15 |
| End Page: | S16 |
| Language: | English |
| ACCESSION: | WOS:001345547300035 |
| DOI: | 10.1016/j.ejca.2024.114563 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 35 (PB023) -- Article number: 114563 -- Source: Wos |
